Skip to content

Novel mHealth Physical Activity Intervention for Youth With Type 1 Diabetes Mellitus

Novel mHealth Physical Activity Intervention for Youth With Type 1 Diabetes Mellitus

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06018844
Enrollment
1
Registered
2023-08-31
Start date
2024-07-25
Completion date
2025-06-26
Last updated
2025-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 1 Diabetes

Brief summary

The goal of this longitudinal cohort study is to learn about a mHealth intervention in Type 1 Diabetes (T1D) The main question\[s\] it aims to answer are: * Does the intervention increase the amount of text messages between the mHealth software and participants? * Do the text messages from the Nudge software increase moderate to vigorous physical activity (MVPA) in participants? * Does the MVPA encouraged by the Nudge software improve the HbA1c levels of participants? Participants will: * Receive text messages from the Nudge software * Report physical activity goals via the text messages to the Nudge software * Wear both an accelerometer and an actigraph for three weeks (spread out across the beginning, 30 days, and 90 days of participation) * Complete surveys at the beginning of participation * Complete daily surveys while wearing the devices * Complete surveys at the end of participation * Record physical activity in study surveys

Interventions

OTHERNUDGE

NUDGE is a brief mHealth text messaging intervention designed to promote activity in adolescents by allowing them to set, monitor, and receive feedback on daily PA goals through text message.

Sponsors

University of Kansas
CollaboratorOTHER
Nemours Children's Clinic
CollaboratorOTHER
Children's Mercy Hospital Kansas City
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
13 Years to 21 Years
Healthy volunteers
No

Inclusion criteria

* Participants 12.00-21.99 years old * Participants with a physician confirmed T1D diagnosis. * T1D diagnosis was at least 6 months prior to study enrollment * Participants are on an intensive insulin regiment (either with an insulin pump or multiple daily injection) * Participants must be using a continuous glucose monitor (CGM) * Participants and parents/legally authorized representatives (LARS) of participants less than 18.00 speak/read English.

Exclusion criteria

* Participants with evidence of type 2 or monogenic diabetes. * Participants with a comorbid chronic condition (e.g., renal disease). * Participants with presence of severe psychiatric disorders. * Participants with a diagnosis of low vision (vision that cannot be corrected with contact lenses or eyeglasses). * Participants with limited mobility that would prevent participant from engaging in daily physical activity, self-assessed by participant.

Design outcomes

Primary

MeasureTime frameDescription
%Daily Text Messages Exchanged Between Youth and the NUDGE BotThrough study completion, an average of 3.5 monthspercent of daily text messages exchanged between youth and the NUDGE bot
Moderate to Vigorous Physical Activity (MVPA) LevelsDay 1, 30 and 90Participants' MVPA levels

Secondary

MeasureTime frameDescription
%Days That Youth Wear the ActigraphDay 1, 30 and 90Percent of days that youth wear the actigraph
%Daily Physical Activity (PA) Schedules That Participants CompleteDay 1, 30 and 90percent of daily PA schedules that participants complete
Change in Participant HbA1cThrough study completion, an average of 3.5 monthsChange in participant HbA1c

Countries

United States

Participant flow

Participants by arm

ArmCount
Primary Arm
Main group of patients 13.00 to 21.99 with T1D
1
Total1

Baseline characteristics

CharacteristicPrimary Arm
Age, Continuous17 years
Ethnicity (NIH/OMB)
Hispanic or Latino
0 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
1 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
Race (NIH/OMB)
Asian
0 Participants
Race (NIH/OMB)
Black or African American
0 Participants
Race (NIH/OMB)
More than one race
0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
Race (NIH/OMB)
White
1 Participants
Sex: Female, Male
Female
1 Participants
Sex: Female, Male
Male
0 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 1
other
Total, other adverse events
0 / 1
serious
Total, serious adverse events
0 / 1

Outcome results

Primary

%Daily Text Messages Exchanged Between Youth and the NUDGE Bot

percent of daily text messages exchanged between youth and the NUDGE bot

Time frame: Through study completion, an average of 3.5 months

Population: Study terminated before analysis took place, due to slow enrollment and unexpected termination the little data collected could not be analyzed.

Primary

Moderate to Vigorous Physical Activity (MVPA) Levels

Participants' MVPA levels

Time frame: Day 1, 30 and 90

Population: Study terminated before analysis took place, due to slow enrollment and unexpected termination the little data collected could not be analyzed.

Secondary

Change in Participant HbA1c

Change in participant HbA1c

Time frame: Through study completion, an average of 3.5 months

Population: Study terminated before analysis took place, due to slow enrollment and unexpected termination the little data collected could not be analyzed.

Secondary

%Daily Physical Activity (PA) Schedules That Participants Complete

percent of daily PA schedules that participants complete

Time frame: Day 1, 30 and 90

Population: Study terminated before analysis took place, due to slow enrollment and unexpected termination the little data collected could not be analyzed.

Secondary

%Days That Youth Wear the Actigraph

Percent of days that youth wear the actigraph

Time frame: Day 1, 30 and 90

Population: Study terminated before analysis took place, due to slow enrollment and unexpected termination the little data collected could not be analyzed.

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026